Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19
Archives of Immunology Research and Therapy · 2023
DOI: 10.58489/2836-5003/006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Immunology Research and Therapy, 2023. Verfasst von Mohitosh Biswas.
Abstract (Originalsprache)
Aims
This study was aimed to investigate predictive prevalence of rs11385942 and rs657152 single nucleotide polymorphisms (SNPs) in the world populations since these were associated with severe COVID-19.
Methods
Genetic data of rs11385942 and rs657152 SNPs of the 26 populations were obtained from the 1000 Genomes project. Phenotypes were assigned as high-risk, medium-risk or no-risk based on the carrying of characteristics risk alleles.
Results
It was demonstrated that the prevalence of risk allele associated with rs11385942 SNP for developing severe COVID-19 was significantly different in various ethnic groups (Chi-square test, p
Zitieren
APA
Biswas, M. (2023). Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19. Archives of Immunology Research and Therapy. https://doi.org/10.58489/2836-5003/006
Vancouver
Biswas M. Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19. Archives of Immunology Research and Therapy. 2023. doi:10.58489/2836-5003/006
BibTeX
@article{Biswas2023,
author = {Biswas, Mohitosh},
title = {Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19},
journal = {Archives of Immunology Research and Therapy},
year = {2023},
doi = {10.58489/2836-5003/006}
}
EUVIMED